Colorectal cancer in post-liver transplant recipients

Diseases of the Colon and Rectum

Volumn 53, Issue 5, 2010, Pages 817-821

  Sint Nicolaas, Jerome ^a   Tjon, Angela S W ^a   Metselaar, Herold J ^a   Kuipers, Ernst J ^a   De Man, Rob A ^a   Van Leerdam, Monique E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Incidence; Liver transplantation; Risk; Screening

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; COLONOSCOPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GRAFT RECIPIENT; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NETHERLANDS; PRIMARY SCLEROSING CHOLANGITIS; RISK FACTOR; SIGMOIDOSCOPY; COLORECTAL TUMOR; FOLLOW UP; INCIDENCE; MIDDLE AGED; REGISTER; SCLEROSING CHOLANGITIS;

CHOLANGITIS, SCLEROSING; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NETHERLANDS; REGISTRIES; RISK FACTORS;

EID: 77951905093     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181cc90c7     Document Type: Article

References (26)

1. Vallejo GH, Romero CJ, de Vicente JC. Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol. 2005;56:87-99.
2. Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol. 2001;34:84-91.
3. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transplantation. 2002;8:482-487.
4. Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer. 1998;83:1237-1243.
5. Silva MA, Jambulingam PS, Mirza DF. Colorectal cancer after orthotopic liver transplantation. Crit Rev Oncol/Hematol. 2005;56:147-153.
6. Delco F, Mullhaupt B. Should we screen for colorectal cancer in liver transplantation? J Hepatol. 2006;44:32-38.
7. van de Vrie W, de Man RA, van Buuren HR, Schouten WR, Tilanus HW, Metselaar HJ. Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 2003;15:657-663.
8. Higashi H, Yanaga K, Marsh JW, Tzakis A, Kakizoe S, Starzl TE. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology. 1990;11:477-480.
9. Bleday R, Lee E, Jessurun J, Heine J, Wong WD. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum. 1993;36:908-912.
10. Loftus EV Jr, Aguilar HI, Sandborn WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology. 1998;27:685-690.
11. Eaden JA, Mayberry JF. Guidelines for screening and surveil- lance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut. 2002;51(suppl 5): V10-V12.
12. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet. 2002;359:1291-1300.
13. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273-275. (Pubitemid 23224421)
14. Dutch Comprehensive Cancer Registry. 2005. http://www.ikcnet.nl/uploaded/ FILES/Landelijk/cijfers/incidentie%202008/A4 (a4a) %202005%20ka.xls. Accessed November 24, 2008.
15. Breslow NE, Day NE. The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1987. Statistical Methods in Cancer Research; vol 2 (IARC Scientific Publication No. 82).
16. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation. 2005;80:759-764.
17. Jiang Y, Villeneuve PJ, Fenton SS, Schaubel DE, Lilly L, Mao Y. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Liver Transplantation. 2008;14:1588-1597.
18. Jain AB, Yee LD, Nalesnik MA, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation. 1998;66:1193-1200.
19. Broome U, Lofberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum. 1995;38:1301-1305.
20. Knechtle SJ, D'Alessandro AM, Harms BA, Pirsch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery. 1995;118:615-620.
21. Fabia R, Levy MF, Testa G, et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg. 1998;176:265-269.
22. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006;130:1872-1885.
23. de Jong AE, Morreau H, Nagengast FM, et al. Prevalence of adenomas among young individuals at average risk for colorectal cancer. Am J Gastroenterol. 2005;100:139-143.
24. de Jong AE, Vasen HF. The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth J Med. 2006;64:367-370.
25. Gruber SA, Matas AJ. Etiology and pathogenesis of tumors occurring after organ transplantation. Transplant Sci. 1994;4:87-104.
26. Rembacken BJ, Fujii T, Cairns A, et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet. 2000;355:1211-1214.